XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Components - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Jul. 16, 2021
Mar. 30, 2020
Mar. 31, 2022
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Disaggregation of Revenue [Line Items]            
Pfizer collaboration revenue       $ 104,996,000 $ 22,354,000 $ 0
Richter            
Disaggregation of Revenue [Line Items]            
Regulatory milestone payments received $ 15,000,000 $ 25,000,000   15,000,000    
ORGOVYX            
Disaggregation of Revenue [Line Items]            
Revenues       82,959,000 3,630,000 0
MYFEMBREE            
Disaggregation of Revenue [Line Items]            
Revenues       6,355,000 0 0
Richter product supply and royalties            
Disaggregation of Revenue [Line Items]            
Revenues       4,995,000 0 0
Richter product supply and royalties | Richter            
Disaggregation of Revenue [Line Items]            
Revenues       4,700,000    
RYEQO | Richter | Maximum            
Disaggregation of Revenue [Line Items]            
Revenues       300,000    
Richter license and milestone revenue            
Disaggregation of Revenue [Line Items]            
Revenues       31,667,000 33,333,000 $ 0
Revenue Recognized Upon Completion of Delivery | Richter            
Disaggregation of Revenue [Line Items]            
Revenues     $ 16,700,000 $ 16,700,000 $ 33,300,000